"Mr Pearce esablished Pearce Pharmaceuticals, a trading company in raw materials for the drug and veterinarian industries as well as packaging for the cosmetics and beauty industry. Mr Pearce expanded this business to create and own Scental Pacific Pty Ltd, a full service contract manufacturer servicing the bath, body and beauty industry. He grew this business to a turnover of over $25 million and in excess of 150 staff. In 1996 Mr Pearce sold Scental Pacific Pty Ltd to the Smorgan family while retaining and expanding his Pearce Pharmaceuticals trading business into the Continental Group. In 2002, Mr Pearce re-established himself as a contract manufacturer in the bath and beauty industry with the acquisition of a small factory. In 2010, he renamed that business as Beautiworx. In 2014, Mr Pearce sold Beautiworx into a company where he was one of the two major shareholders, CEO of the manufacturing arm and a director on the Board. This company, BWX Limited, was successfully listed on the ASX in 2015 with a current market capitalisation of over $400 million being a Brand business vertically integrated with manufacturing and distribution. " "Mr Pearce esablished Pearce Pharmaceuticals, a trading company in raw materials for the drug and veterinarian industries as well as packaging for the cosmetics and beauty industry. Mr Pearce expanded this business to create and own Scental Pacific Pty Ltd, a full service contract manufacturer servicing the bath, body and beauty industry. He grew this business to a turnover of over $25 million and in excess of 150 staff. In 1996 Mr Pearce sold Scental Pacific Pty Ltd to the Smorgan family while retaining and expanding his Pearce Pharmaceuticals trading business into the Continental Group. In 2002, Mr Pearce re-established himself as a contract manufacturer in the bath and beauty industry with the acquisition of a small factory. In 2010, he renamed that business as Beautiworx. In 2014, Mr Pearce sold Beautiworx into a company where he was one of the two major shareholders, CEO of the manufacturing arm and a director on the Board. This company, BWX Limited, was successfully listed on the ASX in 2015 with a current market capitalisation of over $400 million being a Brand business vertically integrated with manufacturing and distribution. "

pharmaceutical Industry